Company	:	Diant Pharma Inc.
Corporate Address	:	130 Utopia Road, Unit 12, Manchester, CT 06042
Offering Minimum	:	$123,999.16
Offering Maximum	:	$1,234,998.32
Minimum Investment Amount (per investor)	:	$498.20

Terms

Offering Type	:	Equity
Security Name	:	Series Seed-2 Preferred Stock
Minimum Number of Shares Offered	:	65,957
Maximum Number of Shares Offered	:	656,914
Price per Share	:	$1.88
Pre-Money Valuation	:	$15,959,855.80

*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives & Bonuses*

Time-Based Perks

Early Bird 1: Invest $1,000 in the first week and receive 5% bonus shares.

Early Bird 2: Invest $5,000 in the first week and receive 6% bonus shares.

Early Bird 3: Invest $10,000 in the first week and receive 8% bonus shares

Early Bird 4: Invest $25,000 in the first week and receive 10% bonus shares

Early Bird 5: Invest $50,000 in the first week and receive 12% bonus shares and an Annual Dinner with Leadership

Volume-Based Perks

Tier 1: Invest $1,000 and receive 2% bonus shares.

Tier 2: Invest $5,000 and receive 3% bonus shares.

Tier 3: Invest $10,000 and receive 5% bonus shares.

Tier 4: Invest $25,000 and receive 7% bonus shares.

Tier 5: Invest $50,000 and receive 10% bonus shares.

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed. Crowdfunding investments made through a self-directed IRA cannot receive non-bonus share perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those non-bonus share perks because they would be receiving a benefit from their IRA account.

The 10% StartEngine Venture Club Bonus

Diant Pharma Inc. will offer 10% additional bonus shares for all investments that are committed by investors who are eligible for the StartEngine Venture Club.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Series Seed-2 Preferred Stock at $1.88 / share, you will receive 110 shares of Series Seed-2 Preferred Stock, meaning you’ll own 110 shares for $188. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor’s eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Venture Club Bonus in addition to the aforementioned bonus.

Tomorrow’s Cures, Delivered Today